Estimates of the changing age-burden of Plasmodium falciparum malaria disease in sub-Saharan Africa.
about
Effects of Response to 2014-2015 Ebola Outbreak on Deaths from Malaria, HIV/AIDS, and Tuberculosis, West AfricaAnalysis of Trend of Malaria Prevalence in the Ten Asian Countries from 2006 to 2011: A Longitudinal StudyMapping Plasmodium falciparum Mortality in Africa between 1990 and 2015Oral, ultra-long-lasting drug delivery: Application toward malaria elimination goalsMathematical Modelling to Guide Drug Development for Malaria EliminationMalaria mapping: understanding the global endemicity of falciparum and vivax malariaHigh-level Plasmodium falciparum sulfadoxine-pyrimethamine resistance with the concomitant occurrence of septuple haplotype in TanzaniaThe effect of malaria control on Plasmodium falciparum in Africa between 2000 and 2015Potential public health impact of RTS,S malaria candidate vaccine in sub-Saharan Africa: a modelling studyThe interaction between seasonality and pulsed interventions against malaria in their effects on the reproduction numberHitting a Moving Target: A Model for Malaria Elimination in the Presence of Population MovementMonitoring changes in malaria epidemiology and effectiveness of interventions in Ethiopia and Uganda: Beyond Garki Project baseline surveyIdentification of three ookinete-specific genes and evaluation of their transmission-blocking potentials in Plasmodium bergheiMalaria mortality in Africa and Asia: evidence from INDEPTH health and demographic surveillance system sites.Immunogenicity of the RTS,S/AS01 malaria vaccine and implications for duration of vaccine efficacy: secondary analysis of data from a phase 3 randomised controlled trialRole of mass drug administration in elimination of Plasmodium falciparum malaria: a consensus modelling studyAge-specific malaria mortality rates in the KEMRI/CDC health and demographic surveillance system in western Kenya, 2003-2010Mapping the denominator: spatial demography in the measurement of progress.Stable malaria incidence despite scaling up control strategies in a malaria vaccine-testing site in Mali.A combined analysis of immunogenicity, antibody kinetics and vaccine efficacy from phase 2 trials of the RTS,S malaria vaccine.Contrasting benefits of different artemisinin combination therapies as first-line malaria treatments using model-based cost-effectiveness analysis.Sixty years trying to define the malaria burden in Africa: have we made any progress?Lead clinical and preclinical antimalarial drugs can significantly reduce sporozoite transmission to vertebrate populations.Calibration of an intrahost malaria model and parameter ensemble evaluation of a pre-erythrocytic vaccine.Screening for an ivermectin slow-release formulation suitable for malaria vector controlDefining the relationship between Plasmodium vivax parasite rate and clinical diseaseSeasonality in malaria transmission: implications for case-management with long-acting artemisinin combination therapy in sub-Saharan Africa.Global database of matched Plasmodium falciparum and P. vivax incidence and prevalence records from 1985-2013.Predicting the impact of border control on malaria transmission: a simulated focal screen and treat campaignDefining the relationship between infection prevalence and clinical incidence of Plasmodium falciparum malaria.Distribution of malaria exposure in endemic countries in Africa considering country levels of effective treatment.Disparities between malaria infection and treatment rates: Evidence from a cross-sectional analysis of households in Uganda.Geographic variation in pneumococcal vaccine efficacy estimated from dynamic modeling of epidemiological data post-PCV7Assessing the potential impact of artemisinin and partner drug resistance in sub-Saharan Africa.Public health impact and cost-effectiveness of the RTS,S/AS01 malaria vaccine: a systematic comparison of predictions from four mathematical modelsThe Relationship Between Invasive Nontyphoidal Salmonella Disease, Other Bacterial Bloodstream Infections, and Malaria in Sub-Saharan Africa.Malaria morbidity and mortality in Ebola-affected countries caused by decreased health-care capacity, and the potential effect of mitigation strategies: a modelling analysis.Assessment of the impact of the malaria elimination programme on the burden of disease morbidity in endemic areas of Iran.Is a reproduction number of one a threshold for Plasmodium falciparum malaria elimination?Malaria intervention scale-up in Africa: effectiveness predictions for health programme planning tools, based on dynamic transmission modelling.
P2860
Q26742220-EB7D0263-88A5-453C-8E98-72B858EFA82AQ26773576-6A28F6F8-0613-4D2A-800C-7BE866C71B99Q27198237-3B556085-7D6E-44C6-9DB4-2CFAE4AE1125Q27901942-CC1DDEC9-5DF9-434F-A8D4-904B3F9E3B80Q28067367-D3CC1E5D-CFF3-4A0F-A0F5-78460F30500DQ28084668-8C1F4ECB-5AA3-4DD2-B05A-18B3E15DC8DEQ28125930-0D7F8AEF-B5B4-4CD5-9042-B35985E52BFBQ28267425-A65653E8-4D30-4CB2-A201-A2F576316A4BQ28397448-552C816F-D868-4C6A-AAAC-9009AFAB3FD0Q28543031-B8B8096B-0B4E-4A2A-AC2B-DA0584A40063Q28551653-732CA757-13BC-4955-9F6E-A0584074158EQ28608078-B71C4DFB-F7B6-406C-97EF-460D09A7A073Q30043378-093841AB-3E90-44DC-8DA6-50D380E98EFFQ30868273-79865E20-2648-495B-91D7-F0FB95B03BA2Q30991737-3BE42496-D5E0-4EF7-B68E-AB911D6648A1Q33794662-E2B08CCD-FD5E-46D5-8DD0-44C0DBEBE2A7Q34121276-B58BCA2D-D843-4C0B-A325-2E7E9A7971F0Q34169711-362AEDC7-11BA-4825-BAB7-360B31432DF6Q34271312-2F174043-02F6-49B1-9A21-5AF77AF8EAC8Q34487139-321F765B-D558-4706-B387-4FABE5A9001DQ34677891-E6B44E5A-F32A-4B98-88DB-17CEED673CDBQ34694657-C4826112-2D37-4FCB-AFEB-418118DD72CBQ34922792-093FC476-574A-49DC-BE54-15D15FAF77C6Q35079044-5347C4B2-11D7-42AA-802D-D91337AA571DQ35163829-5574FCC0-6D47-4491-9477-DD33F5D5F272Q35601197-66FBE3E7-5E04-4D5C-B7BC-19C47A860B6CQ35748391-C261332A-543A-421D-AEED-BC4527EF3F6FQ35755023-CCC3D6D1-663A-4155-B894-C2A86D517224Q35842716-DEDA3F48-ADD4-4E16-8F4A-C893A84341ABQ36059380-37872785-8F61-413B-900F-85B739BDE1BFQ36127097-18BF0FDF-B73E-488E-914F-D7C99643AC73Q36291546-A24E856B-62A3-441E-B86D-C756FC523971Q36399999-F5AB2639-6261-4E11-A9AA-AB49D4700ECDQ36439747-A18FC28E-FB30-4950-9BB1-C8E5F0FA34B3Q36492529-CF2F0A82-F868-49A0-BD24-CF939DD4F47DQ36635676-5B66BDB6-46D8-486C-9B28-46F05E6F500DQ36775852-B5649DE2-081D-4809-B127-A5929A362A84Q36796959-FBC8E39F-B840-45DB-8C0C-ACDDD7215E51Q37125879-073FB28F-A0CC-4F5A-9296-CCAD28DA5594Q37189454-A0B7A6F3-DD93-4099-845B-0F2EBD9886EF
P2860
Estimates of the changing age-burden of Plasmodium falciparum malaria disease in sub-Saharan Africa.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Estimates of the changing age- ...... disease in sub-Saharan Africa.
@en
Estimates of the changing age- ...... disease in sub-Saharan Africa.
@nl
type
label
Estimates of the changing age- ...... disease in sub-Saharan Africa.
@en
Estimates of the changing age- ...... disease in sub-Saharan Africa.
@nl
prefLabel
Estimates of the changing age- ...... disease in sub-Saharan Africa.
@en
Estimates of the changing age- ...... disease in sub-Saharan Africa.
@nl
P2860
P921
P356
P1476
Estimates of the changing age- ...... disease in sub-Saharan Africa.
@en
P2093
Jamie T Griffin
P2860
P2888
P356
10.1038/NCOMMS4136
P407
P577
2014-01-01T00:00:00Z